Halvorsen Pharma pays $2.1B for Calder Bio. Why the price held.
Yemi Adebayo · 4 min
Rounds
Rounds — Capital, AI, and medicine
Deals & CapitalDemo7 min read
Veridian Genomics's $4.2B exit was a cap-table lesson, not a victory lap.
The headline price made the news. The investor returns tell a different story.
Top Stories
See all top storiesDeals & CapitalDemo
AI & AlgorithmsDemo
Multimodal AI clears a regulatory hurdle. Payers haven't caught up.
Priya Sharma · 6 min
Global BriefDemo
Inside Lagos: how Africa's quietest digital-health hub built a $400M pipeline.
Tobi Opeyemi Amure · 8 min
Editor's Desk
View more editor picks
AI & AlgorithmsDemo9 min
The new payments stack for biotech treasuries.
Stablecoin rails, USD multi-currency wallets, and why clinical-stage CFOs will think about money the way fintech CFOs do.
Deals & CapitalDemo11 min
Why Series B is the hardest round in AI-bio right now.
The gap between seed enthusiasm and growth-stage rigor has never been wider.
The Lab
Browse all research
Phase IIIDemo
The LabKST-204: a quiet readout that resets NF2 economics.
Phase IIDemo
The LabMachine-learned ALS targets clear their first human bar.
Most Read
See all most-read storiesDemo edition
1
Deals & CapitalDemo
Veridian Genomics's $4.2B exit was a cap-table lesson, not a victory lap.
2
Deals & CapitalDemo
Why Series B is the hardest round in AI-bio right now.
3
The OperatorDemo
Hospital procurement isn't broken. The vendors are.
4
AI & AlgorithmsDemo
Multimodal AI clears a regulatory hurdle. Payers haven't caught up.
Contributors
Meet our contributorsTA
Tobi Opeyemi Amure
Founder & Editor, Rounds
Tobi Opeyemi Amure is a freelance finance and technology journalist with seven years of experience. His bylines include Forbes, Inc., Investopedia, TheStreet, Benzinga, TipRanks, FinanceFeeds and GOBankingRates. He holds the CFEI® credential.
AP
Dr. Aisha Patel
CIO, Bayview Health System
Fictional contributorAisha writes The Operator column on hospital IT, procurement, and the realities of getting software through a health system.
DC
David Chen
Partner, Northline Ventures
Fictional contributorDavid covers early-stage AI-bio from a board-seat perspective. He invests where biology meets software.
OS
Dr. Olu Sangoyomi
Founder, AfriaMed
Fictional contributorOlu writes from Lagos on the African digital-health stack — clinical trials, telehealth, and payments rails.
PS
Priya Sharma
Senior Reporter
Fictional contributorPriya covers FDA, CMS, and the algorithms moving through both. Previously at Fieldnote Health and Ledgerline News.
YA
Yemi Adebayo
Markets Reporter
Fictional contributorYemi covers the public-market reaction to deals and clinical readouts. Trained as an equity analyst.
